Key result
Nomogram combining TEG, age, and NT-proBNP predicts in-stent restenosis post-PCI with ~0.75 AUC.
Why the study?
In-stent restenosis is a serious complication after PCI, motivating the development and validation of a prediction model integrating TEG parameters, coagulation function, and clinical indicators.
Does a prediction model incorporating thromboelastography parameters, age, and NT-proBNP accurately predict in-stent restenosis in coronary artery disease patients after PCI on dual antiplatelet therapy?
Cohort (n=401)
No
Does a prediction model incorporating thromboelastography parameters, age, and NT-proBNP accurately predict in-stent restenosis in coronary artery disease patients after PCI on dual antiplatelet therapy?
Effect estimate: AUC 0.752 (95% CI 0.702-0.803)
A novel prediction model incorporating thromboelastography parameters, age, and NT-proBNP effectively identifies patients at high risk for in-stent restenosis after PCI, providing a tool to guide individualized antiplatelet therapy.
Supports vigilant post-stent surveillance in similar cohorts; leaves open prospective validation of risk prediction tools before practice integration.
Objectives In-stent restenosis (ISR) is a serious complication that occurs after a percutaneous coronary intervention (PCI). This study aims to integrate thromboelastography (TEG) parameters, coagulation function, and clinical indicators to develop and validate a prediction model for ISR during antiplatelet therapy after PCI. Method A total of 401 consecutive patients with coronary artery disease who underwent a PCI with drug-eluting stent implantation between January 2018 and January 2024 were enrolled in this study. Clinical baseline characteristics were collected. The Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to screen 6 key predictors from 34 candidate clinical features. Multivariate logistic regression identified independent risk factors for ISR. Model performance was evaluated using the receiver operating characteristic curve for discrimination, bootstrap internal validation for stability, the Hosmer–Lemeshow test for goodness of fit, and decision curve analysis for clinical utility. Results Among the 401 enrolled patients, 137 (34.2%) developed ISR. LASSO regression selected 6 key predictors from 34 candidate variables. Multivariable logistic regression ultimately identified a low adenosine diphosphate (ADP) inhibition rate, a low arachidonic acid (AA) inhibition rate, reaction time ( R -value), and age as independent risk factors for ISR. The constructed nomogram demonstrated good discrimination (area under the curve = 0.752, 95% confidence interval: 0.702–0.803), stable performance upon bootstrap internal validation, and satisfactory calibration (Hosmer–Lemeshow test, P = 0.320). Furthermore, decision curve analysis indicated a favorable clinical net benefit across a broad range of threshold probabilities. Conclusions The prediction model, constructed based on TEG parameters (ADP inhibition rate, AA inhibition rate, R -value), age, and N-terminal pro-B-type natriuretic peptide, effectively identifies patients at high risk for ISR after a PCI. It provides a basis for individualized antiplatelet therapy and postoperative management decisions.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Coronary artery disease (n=401). Prediction model (nomogram) was evaluated on Model discrimination for in-stent restenosis (AUC 0.752, 95% CI 0.702-0.803). A constructed nomogram incorporating thromboelastography parameters, age, and NT-proBNP effectively predicted in-stent restenosis after percutaneous coronary intervention with an AUC of 0.752.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: